Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The firm bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.
How did QCLS's recent EPS compare to expectations?
The most recent EPS for Q/C Technologies Inc is $, expectations of $.
How did Q/C Technologies Inc QCLS's revenue perform in the last quarter?
Q/C Technologies Inc revenue for the last quarter is $
What is the revenue estimate for Q/C Technologies Inc?
According to of Wall street analyst, the revenue estimate of Q/C Technologies Inc range from $ to $
What's the earning quality score for Q/C Technologies Inc?
Q/C Technologies Inc has a earning quality score of A-/59.57667. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Q/C Technologies Inc report earnings?
Q/C Technologies Inc next earnings report is expected in 2026-02-15
What are Q/C Technologies Inc's expected earnings?
Q/C Technologies Inc expected earnings is $, according to wall-street analysts.
Did Q/C Technologies Inc beat earnings expectations?
Q/C Technologies Inc recent earnings of $ expectations.